The Effect of Biological Treatment on Stress Parameters Determined in Saliva in Patients with Severe Psoriasis

被引:2
作者
Foks-Ciekalska, Aleksandra [1 ]
Jarzab, Jerzy [1 ]
Hadas, Ewa [1 ]
Swietochowska, Elzbieta [2 ]
Gumieniak, Kamila [3 ]
Ciekalski, Wiktor [4 ]
Bozek, Andrzej [1 ]
机构
[1] Med Univ Silesia, Clin Dept Internal Dis Dermatol & Allergol Zabrze, PL-40055 Katowice, Poland
[2] Med Univ Silesia, Fac Med Sci Zabrze, Dept Med & Mol Biol, Ul Jordana 19, PL-41808 Zabrze, Poland
[3] Municipal Hosp 4, Dept Internal Med Nephrol Subvis, PL-44100 Gliwice, Poland
[4] Municipal Hosp, Dept Internal Med, PL-41803 Zabrze, Poland
来源
MEDICINA-LITHUANIA | 2023年 / 59卷 / 04期
关键词
psoriasis; stress; psychodermatology; saliva; QUALITY-OF-LIFE; ALPHA-AMYLASE; CHROMOGRANIN-A; PSYCHOLOGICAL STRESS; HEALTH; REACTIVITY; CORTISOL; IMMUNITY; OUTCOMES; INDEX;
D O I
10.3390/medicina59040692
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives: In psoriatic patients, stress is the most common aggravating factor. Despite the use of quality-of-life assessment questionnaires, diagnosing stress in psoriatic patients is not a flawless procedure. This study aimed to assess the usefulness of potential stress biomarkers in saliva for monitoring the treatment of psoriasis. Materials and methods: A total of 104 adult patients with severe psoriasis were included and randomly treated via biological treatment or symptomatic therapy: 84 received biological treatment, with 20 formed a control group receiving symptomatic therapy. The administered biological treatment was adalimumab, whilst in controls calcipotriol/betamethasone dipropionate topical gel and emollients were used. Patients were monitored monthly with a dermatological examination and the dispensing of a biological drug. During each of the four visits, the severity of the disease was assessed (PASI, BSA, and DLQI), and a sample of the patient's saliva was taken. In all the participants, the saliva concentrations of immunoglobulin A (sIgA), alpha-amylase (sAA), and chromogranin A (CgA) were measured. Results: The majority of patients in both the study and control groups achieved clinical improvement, though favoring the group receiving biological treatment. The concentration of sIgA in the saliva was constantly increasing in the study group during subsequent visits (Fr = 27.26; p < 0.001). Meanwhile, there were no statistically significant changes in the control group during the same follow-up period (Fr = 6.66; p = 0.084). Levels of sAA underwent statistically significant changes in both groups (Fr = 58.02; p < 0.001-study group and Fr = 13.74; p = 0.003-control group). In the study group, a steady, statistically significant increase in sAA was observed from the first to the third visit. In the study group, a downward trend in CgA concentration was observed. In the control group, no significant differences in the level of CgA were obtained. Conclusions: sIgA, sAA, and CgA are potential markers of the severity of psoriasis and the associated stress reaction. Based on the presented observations, only sIgA and CgA seem to be valuable biomarkers for monitoring the effectiveness of the systemic treatment of psoriasis.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] ASSESSMENT OF SOME OXIDATIVE STRESS PARAMETERS IN METHOTREXATE TREATED PSORIASIS PATIENTS
    Boda, Daniel
    Negrei, Carolina
    Nicolescu, Florica
    Balalau, Cristian
    FARMACIA, 2014, 62 (04) : 704 - 710
  • [22] Parameters of oxidative stress in saliva from diabetic and parenteral drug addict patients
    Arana, Carlos
    Cutando, Antonio
    Ferrera, Maria Jose
    Gomez-Moreno, Gerardo
    Vander Worf, Cecilia
    Jorge Bolanos, Manuel
    Escames, Germaine
    Acuna-Castroviejo, Dario
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2006, 35 (09) : 554 - 559
  • [23] Australian consensus: Treatment goals for moderate to severe psoriasis in the era of targeted therapies - Adult patients
    Foley, Peter
    Gebauer, Kurt
    Sullivan, John
    McMeniman, Erin
    Shumack, Stephen
    Ng, Jonathan
    James, Amelia
    Rawlin, Morton
    Sidhu, Shireen
    Tillakaratne, Dev
    Turner, Murray
    Radulski, Barbara
    Nash, Peter
    Baker, Christopher
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2023, 64 (04) : 476 - 487
  • [24] Validation and response to treatment of a pruritus self-assessment tool in patients with moderate to severe psoriasis
    Gottlieb, Alice
    Feng, JingYuan
    Harrison, David J.
    Globe, Denise
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 63 (04) : 580 - 586
  • [25] Influence of psychological stress on non-surgical periodontal treatment outcomes in patients with severe chronic periodontitis
    Petit, Catherine
    Anadon-Rosinach, Victor
    Rettig, Laurence
    Schmidt-Mutter, Catherine
    Tuzin, Nicolas
    Davideau, Jean-Luc
    Huck, Olivier
    JOURNAL OF PERIODONTOLOGY, 2021, 92 (02) : 186 - 195
  • [26] The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: A randomized clinical trial
    Menter, Alan
    Augustin, Matthias
    Signorovitch, James
    Yu, Andrew P.
    Wu, Eric Q.
    Gupta, Shiraz R.
    Bao, Yanjun
    Mulani, Parvez
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 62 (05) : 812 - 818
  • [27] A changed life: the life experiences of patients with psoriasis receiving biological treatment
    Trettin, B.
    Feldman, S. R.
    Andersen, F.
    Danbjorg, D. B.
    Agerskov, H.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (03) : 516 - 523
  • [28] Management of Patients with Psoriasis Treated with Biological Drugs Needing a Surgical Treatment
    Fabiano, Antonella
    De Simone, Clara
    Gisondi, Paolo
    Piaserico, Stefano
    Lasagni, Claudia
    Pellacani, Giovanni
    Conti, Andrea
    DRUG DEVELOPMENT RESEARCH, 2014, 75 : S24 - S26
  • [29] Improving management of psoriasis patients receiving biological treatment: A qualitative approach
    Trettin, Bettina
    Feldman, Steven
    Andersen, Flemming
    Danbjorg, Dorthe B.
    Agerskov, Hanne
    NURSING OPEN, 2021, 8 (03): : 1283 - 1291
  • [30] It is not always about gains: utilities and disutilities associated with treatment features in patients with moderate-to-severe psoriasis
    Umar, Nasir
    Schoellgen, Ina
    Terris, Darcey D.
    PATIENT PREFERENCE AND ADHERENCE, 2012, 6 : 187 - 194